Smith+Nephew Receives FDA Clearance for LANDMARK Total Knee System, Completes First Surgeries
Smith+Nephew, a global medical technology company, has announced that its LANDMARK Total Knee System has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). Concurrently, the company has completed the first surgical cases using this new knee replacement solution. The LANDMARK Knee System is designed to mimic healthy knee anatomy and natural motion, offering a more personalized approach to total knee arthroplasty. This system is specifically engineered to integrate with the CORI KNEE Handheld Robotics Arthroplasty, a compact and mobile robotic system suitable for both hospital and ambulatory surgery center environments. Key features of the LANDMARK Knee include its design to restore natural motion and A/P position with minimal compromise, a smooth trochlear groove for natural patella tracking, and a fully 3D-printed femoral component utilizing CONCELOC Technology. Dr. Steven MacDonald and Dr. Steven Haas, who were involved in the design and development, performed the initial surgerie...
